Topic outline

  • General

    • Certificate issue 修了証発行
      Restricted Not available unless:
      • The activity questionnaire_01 is marked complete
      • The activity questionnaire_02 is marked complete
      • The activity questionnaire_03 is marked complete
      • The activity questionnaire_04 is marked complete
      • The activity questionnaire_05 is marked complete
      • The activity questionnaire_06 is marked complete
      • The activity questionnaire_07 is marked complete

  • Precision Treatment and Translational Data Integration for Sarcomas and Rare Cancers | ATLAS Webinar Jan 2026

    [Topic] Precision Treatment and Translational Data Integration for Sarcomas and Rare Cancers

    [Date] 28 January 2026 


    [Opening Remarks] 0:00:00~

    Opening Remarks and Introduction of ATLAS

    Speaker: Dr. Yuta Sekino

    (General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)


    [Lecture 1] 0:06:25～

    Precision radiotherapy for sarcomas and other rare cancers

    Speaker: Dr. Wong Ru Xin

    (Icon Cancer Centre, Singapore)


    [Lecture 2] 0:26:10~

    Data Integration & Multi-Institutional Efforts for Translational Sarcoma Research

    Speaker: Dr. Woo Xing Yi

    (A*STAR Bioinformatics Institute, Singapore)


    [Discussion] 0:52:13~

    Discussion

    Facilitator: Dr. Valerie Yang Shiwen

    (OncoCare Cancer Centre, Singapore)


  • Biliary Tract Cancer (BTC) | ATLAS Webinar Feb 2026

    [Topic] Biliary Tract Cancer (BTC)

    [Date] 26 February 2026 


    [Opening Remarks] 0:00:00~

    Opening Remarks and Introduction of ATLAS

    Speaker: Dr. Yuta Sekino

    (General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)


    [Lecture 1] 0:08:40~

    Epidemiology and Clinical Practice of Biliary Tract Cancer in Southeast Asia

    Speaker: Dr. Thanachai Sanlung

    (Khon Kaen University, Thailand)


    [Lecture 2] 0:34:14~

    Current Standard and Future Perspectives of Immunotherapy for BTC

    Speaker: Dr. Do-Youn Oh

    (Seoul National University Hospital, South Korea)


    [Discussion] 1:13:44~ 

    Discussion

    Facilitator: Dr. Li-Tzong Chen

    (Kaohsiung Medical University Chung-Ho Memorial Hospital, Taiwan)

    Facilitator: Dr. Chigusa Morizane

    (National Cancer Center, Japan)


  • US & UK Clinical Trial Environment | ATLAS Webinar Mar 2026

    [Topic] US & UK Clinical Trial Environment

    [Date] 12 March 2026 


    [Opening Remarks] 0:00:00~

    Opening Remarks and Introduction of ATLAS

    Speaker: Dr. Yuta Sekino

    (General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)


    [Lecture 1] 0:07:24~

    Navigating the US Clinical Trial Landscape: Operations, Regulations, and Financials

    Speaker: Ms. Tomomi Hata

    (National Cancer Center, Japan)


    [Lecture 2] 0:32:45~

    Clinical Research in the UK: The Centralized NHS Model and Evolving Regulatory Pathways

    Speaker: Ms. Celia St Clair

    (National Cancer Center, Japan)


    [Discussion] 1:02:35~ 

    Discussion

    Facilitator: Dr. Yuta Sekino

    (General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)


  • Immunotherapy in treatment of locally advanced SCCHN - current paradigms and unmet needs | ATLAS Webinar Apr 2026

    [Topic] Immunotherapy in treatment of locally advanced SCCHN - current paradigms and unmet needs

    [Date] 24 April 2026 


    [Opening Remarks] 0:00:00~

    Opening Remarks and Introduction of ATLAS

    Speaker: Dr. Mitsumi Terada

    (Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan)


    [Lecture 1] 0:05:41~

    Perioperative immunotherapy in head and neck cancer – hope or hype

    Speaker: Dr. Gopal Iyerw

    （National Cancer Centre, Singapore)


    [Lecture 2] 0:23:44~

    Current Status and Future Directions of Combination Therapy in HNSCC

    : Strategic Optimization in Locally-Advanced and Recurrent or Metastatic Disease 

    Speaker: Dr. Kao Hsiang Fong

    (National Taiwan University Hospital, Taiwan)


    [Discussion] 0:42:11~

    Discussion

    Facilitator: Dr. Mitsumi Terada

    (Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan)


  • Implementing WHA75.8: Regional clinical trial landscape and strengthening institutional capabilities | ATLAS Webinar May 2026

    [Topic] Implementing WHA75.8: Regional clinical trial landscape and strengthening institutional capabilities

    [Date] 22 May 2026 


    [Opening Remarks] 0:00:00~

    Opening Remarks and Introduction of ATLAS

    Speaker: Dr. Mitsumi Terada

    (Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan)


    [Lecture 1] 0:06:58~

    Regional landscape of clinical trial ecosystems

    Speaker: Ms. Mengji Chen

    （WHO Regional Office for the Western Pacific)


    [Lecture 2] 0:25:26~

    WHO Benchmarking Tool for Institutional Capability for Clinical Trials 

    Speaker: Ms. Suzanne Ong

    （WHO Regional Office for the Western Pacific)


    [Discussion] 0:44:27~

    Discussion

    Facilitator: Dr. Mitsumi Terada

    (Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan)


  • Advancing Pediatric Oncology in Asia: Emerging Strategies in Drug Development and Liquid Biopsy | ATLAS Webinar Jun 2026

    [Topic] Advancing Pediatric Oncology in Asia: Emerging Strategies in Drug Development and Liquid Biopsy

    [Date] 26 June 2026 


    [Opening Remarks] 0:00:00~

    Opening Remarks and Introduction of ATLAS

    Speaker: Dr. Mitsumi Terada

    (National Cancer Center Hospital, Japan)


    [Lecture 1] 0:05:52~

    Current Status of Drug Development in Pediatric Oncology in Japan and the Future Perspectives of the ATLAS Pediatric Oncology Group

    Speaker: Dr. Ayumu Arakawa

    （National Cancer Center Hospital, Japan)


    [Lecture 2] We apologize that this lecture is undisclosed according to the lecturer's preference.


    [Closing Remarks] 0:20:04~

    Speaker: Dr. Ayumu Arakawa

    （National Cancer Center Hospital, Japan)


  • Precision Medicine in Lung Cancer | ATLAS Webinar Jul 2026

    [Topic] Precision Medicine in Lung Cancer

    [Date] 24 July 2026 


    [Opening Remarks] 0:00:00~

    Opening Remarks and Introduction of ATLAS

    Speaker: Dr. Mitsumi Terada

    (National Cancer Center Hospital, Japan)


    [Key note] 0:05:38~

    Precision Medicine in Lung Cancer: The Importance of Biomarker Testing

    Speaker: Dr. Voon Pei Jye

    (Sarawak General Hospital, Malaysia) 


    [Panel talk] 0:36:45~

    Contrasting genetic testing and treatment access between Malaysia and Japan

    Speaker: Dr. Hidehito Horinouchi

    (National Cancer Center, Japan) 


    [Discussion] 1:01:09~

    Facilitator: Dr. Mitsumi Terada

    （National Cancer Center Hospital, Japan)


  • From PATHWAY to the Future: Advancing Breast Cancer Clinical Trials and Collaboration in Asia | ATLAS Webinar Aug 2026

    [Topic] From PATHWAY to the Future: Advancing Breast Cancer Clinical Trials and Collaboration in Asia

    [Date] 20 August 2026 


    [Opening Remarks] 0:00:00~

    Opening Remarks and Introduction of ATLAS

    Speaker: Dr. Mitsumi Terada

    (National Cancer Center Hospital, Japan)


    [Speaker1] 0:06:31~

    The PATHWAY Study at ASCO 2026 and Beyond: Challenges, Opportunities, and Future Directions for Breast Cancer Clinical Trials in Asia 

    Speaker: Dr. Yap Yoon Sim

    (National Cancer Centre, Singapore) 


    [Panel talk] 0:29:31~

    How to Manage the Output of Clinical Trial Results to Scientific Societies and Publications

    Speaker: Dr. Kazuki Sudo

    (National Cancer Center Hospital, Japan) 


    [Discussion] 0:57:57~

    Facilitator: Dr. Kan Yonemori

    (National Cancer Center Hospital, Japan)